Cytokinetics (CYTK) Market Cap 2004–2026

As of October 29, 2026, Cytokinetics had a market cap of $8.785 billion, which increased by 3.32% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Oct 29, 2026, 4:00 PM ET
Cytokinetics logo

Cytokinetics, Inc. (CYTK)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$8.785B ▲ 3.32%
Start of 2026
$7.769B ▲ 13.08%
1 Year Ago
$7.602B ▲ 15.56%
All-Time High
$10.99B ▼ 20.06%


Loading data...


Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Cytokinetics Market Cap History by Year and Month

Cytokinetics Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$8.785B▲ 13.08%
$8.785B▼ 3.95%
$9.146B▼ 7.05%
$9.84B▲ 2.69%
$9.582B▼ 9.43%
$10.58B▲ 1.54%
$10.42B▲ 32.25%
$7.879B▼ 2.94%
$8.118B▲ 6.72%
$7.607B▼ 1.54%
$7.726B▼ 0.55%
2025$7.769B▲ 39.71%
2024$5.561B▼ 32.07%
2023$8.186B▲ 88.79%
2022$4.336B▲ 12.19%
All market cap values reflect closing prices for the period shown.

📊 Cytokinetics Market Cap and Other Industry Peers

Below are selected companies from the Biotechnology sector / subsector:


Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.